Nuvation Bio Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$775M
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Nuvation Bio's estimated annual revenue is currently $7.6M per year.(?)
  • Nuvation Bio's estimated revenue per employee is $201,000
  • Nuvation Bio's total funding is $775M.

Employee Data

  • Nuvation Bio has 38 Employees.(?)
  • Nuvation Bio grew their employee count by 41% last year.
  • Nuvation Bio currently has 1 job openings.

Nuvation Bio is a biopharmaceutical company focused on revolutionizing cancer treatment by discovering, developing and delivering therapies that tackle some of the greatest needs in oncology. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.